IP Library › Granted Patent US 7,105,331
Granted Patent B2
US 7,105,331 · App. 10/439,676 · Granted Sep 12, 2006

ICE/CED-3 like protease designated FMH-1

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,105,331
App. No.
10/439,676
Granted
Sep 12, 2006
Kind
B2
Abstract

Polynucleotides encoding novel proteases designated “FMH-1” are disclosed. Host cells transformed with such polynucleotides and methods for making FMH-1 proteases are also disclosed. The invention also provides FMH-1 proteases and antibodies that react with them, along with pharmaceutical compositions comprising FMH-1 proteases or polynucleotides encoding FMH-1 proteases. Methods for treating conditions associated with excessive or insufficient apoptosis by administering such pharmaceutical compositions are also disclosed.

Claims (1)

1. An isolated protein comprising the amino acid sequence of SEQ ID NO:2.

Assignments (2)
CHANGE OF NAME Recorded Nov 14, 2005
From: GENETICS INSTITUTE, INC.
To: GENETICS INSTITUTE, LLC
Reel/Frame 017229/0609 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2005
From: BOWMAN, MICHAEL
To: GENETICS INSTITUTE, INC.
Reel/Frame 017230/0052 →